Sawai Pharmaceutical Co., Ltd. provided earnings guidance for the fiscal year ending March 31, 2021. For the period, the company expects sales of JPY 200,200 million, Operating profit of JPY 26,850 million, Profit attributable to owners of parent of JPY 20,050 million and Basic earnings per share of JPY 457.85.